-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CA/dsSp2cz2djkSigdDaOBSSB1TauKZbIjUp5MCgntt+w8hsOhZKm91T3D6iqNq1 0zE9eDns9a5f9C0XO67KmA== 0000950153-05-000323.txt : 20050222 0000950153-05-000323.hdr.sgml : 20050221 20050222125211 ACCESSION NUMBER: 0000950153-05-000323 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050210 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20050222 DATE AS OF CHANGE: 20050222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ORTHOLOGIC CORP CENTRAL INDEX KEY: 0000887151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 860585310 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21214 FILM NUMBER: 05630180 BUSINESS ADDRESS: STREET 1: 1275 WEST WASHINGTON STREET CITY: TEMPE STATE: AZ ZIP: 85281 BUSINESS PHONE: 6024375520 MAIL ADDRESS: STREET 1: 1275 WEST WASHINGTON STREET CITY: TEMPE STATE: AZ ZIP: 85281 8-K 1 p70256e8vk.htm 8-K e8vk
 

 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report: February 10, 2005
(Date of earliest event reported)

ORTHOLOGIC CORP.

(Exact name of registrant as specified in its charter)
         
Delaware   000-21214   86-0585310
         
(State or other jurisdiction of
incorporation) 		  (Commission File Number)   (I.R.S. Employer
Identification No.)
     
1275 West Washington Street, Tempe, Arizona   85281
     
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code:
(602) 286-5520

     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

 

Section 1 – Registrant’s Business and Operations

Item 1.01 Entry into a Material Definitive Agreement.

     This Form 8-K is to describe ordinary course executive officer compensation actions taken by the Compensation Committee of OrthoLogic Corp. (the “Company”) and ratified by the Company’s Board of Directors (the “Board”) at a meeting of the Board on February 10, 2005.

     The Board ratified the following actions with respect to the compensation of the Company’s named executive officers (as defined in Regulation S-K, Item 402(a)(3)):

                 
EXECUTIVE OFFICER   2005 SALARY     2004 BONUS(1)  
Chief Executive Officer
Thomas R. Trotter
   $ 350,000 (2)   $ 157,500  
Senior Vice President & Chief Financial Officer
Sherry A. Sturman
   $ 200,000 (2)   $ 85,500  
Senior Vice President of Research and Clinical Affairs and Chief Technology Officer
James T. Ryaby, Ph.D.
   $ 235,000     $ 85,500  

(1)   Bonuses were determined in accordance with the Company’s Management Bonus Plan, which is based upon the financial performance of the Company and other specific company-wide objectives established by the Compensation Committee and approved by the full Board of Directors. The cash bonuses for the Company’s Chief Executive Officer and two other named executive officers were calculated as a percentage of each officer’s respective salary.
 
(2)   No salary increase for 2005.

 

 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
Dated: February 21, 2005  ORTHOLOGIC CORP.
 		  
  /s/ Sherry A. Sturman    
  Sherry A. Sturman   
  Chief Financial Officer   
 

 

-----END PRIVACY-ENHANCED MESSAGE-----